India’s Approval of Own Covid Vaccine Criticised for Lack of Data
India on Sunday granted emergency approval to Bharat Biotech’s Covaxin but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine. The news, announced by